Fe۳O۴@Ag Nanoprobe for Detection of Ovarian Cancer Cell Line Using Magnetic Resonance Imaging

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 140

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JIML-5-2_005

تاریخ نمایه سازی: 7 اسفند 1401

Abstract:

Background and Aims: Magnetic resonance imaging (MRI) plays an essential role in molecular imaging by delivering the contrast agent into targeted cells. The aim of this study was to evaluate the use of magnetic nanoparticles containing iron oxide and silver (Fe۳O۴@Ag core-shell nanoprobe) as a contrast agent for the detection of ovarian cancer cell line ovcar-۳. Materials and Methods: Co-precipitation method was used for synthesis of Fe۳O۴Ag nanoprobe which was then characterized by Fourier transform infrared spectroscopy (FTIR), dynamic light scattering (DLS) and scanning electron microscope (SEM). To evaluate the ability of this nanoprobe in detection of the ovcar-۳ cell line by MRI, the cells were exposed to different (۵ to ۵۰ µg/mL) concentrations of Fe۳O۴@Ag nanoprobe before contrast intensity calculation by MRI.  Results: SEM images revealed that Fe۳O۴@Ag nanoparticles are spherical, about ۱۰۰ nm. FTIR showed strong absorbance picks belonging to the stretching vibration of Ag and Fe-O. It was found that contrast intensity of Fe۳O۴@Ag nanoprobe decreases as concentration decreases. Statistical analysis revealed significant difference in concentrations of ۳۰, ۴۰ and ۵۰ μg/mL, compared to control (p<۰.۰۵). In the presence of Ovcar-۳ cells, higher concentrations (۱۰, ۲۰, and ۳۰ μg/mL) of nanoparticles also significantly increased contrast intensity in comparison with control (p<۰.۰۵). Conclusions: This novel magnetic nanoparticle can be used as an effective contrast agent for improving MRI in detection of ovarian cancer cells. The sensitivity of this contrast agent may be improved by binding to targeting molecules such as antibody and aptamer.

Authors

Shiva Aghaei

Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Seyedhossein Hekmatimoghaddam

Department of Advanced Medical Sciences and Technologies, Faculty of Paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. ۳Department of Laboratory Sciences, Faculty of Paramedicine, Shahid Sadoughi University of Medical Sciences, Yaz

Mehdi Kalantar

Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Mohammad Hassan Sheikha

Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Mohammad Sobhan

Department of Radiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Ali Jebali

Department of Advanced Medical Sciences and Technologies, Faculty of Paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. ۳Department of Laboratory Sciences, Faculty of Paramedicine, Shahid Sadoughi University of Medical Sciences, Yaz

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • . Chinen AB, Guan CM, Ferrer JR, Barnaby SN, Merkel ...
  • . A G N. The importance of early diagnosis in ...
  • . Schiffman JD, Fisher PG, Gibbs P. Early detection of ...
  • . Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for ...
  • . Prat J. Pathology of cancers of the female genital ...
  • . Sohaib SAA, Reznek RH. MR imaging in ovarian cancer. ...
  • . Mohaghegh P, Rockall AG. Imaging strategy for early ovarian ...
  • . Qayyum A, Coakley FV, Westphalen AC, Hricak H, Okuno ...
  • . Kurtz AB, Tsimikas JV, Tempany CMC, Hamper UM, Arger ...
  • . van Nagell JR Jr, Hoff JT. Transvaginal ultrasonography in ...
  • . Chen Y, Zhang L, Hao Q. Candidate microRNA biomarkers ...
  • . Su Z, Graybill WS, Zhu Y. Detection and monitoring ...
  • . Badgwell D, Bast RC Jr. Early detection of ovarian ...
  • . Bulte JWM, Kraitchman DL. Iron oxide MR contrast agents ...
  • . Peng XH, Qian X, Mao H, Wang AY, Chen ...
  • . Yigit MV, Moore A, Medarova Z. Magnetic nanoparticles for ...
  • . Song G, Chen M, Zhang Y, Cui L, Qu ...
  • . Kheiri Manjili H, Ma’mani L, Tavaddod S, Mashhadikhan M, ...
  • . Salehizadeh H, Hekmatian E, Sadeghi M, Kennedy K. Synthesis ...
  • . Hernandez L, Kim MK, Lyle LT, Bunch KP, House ...
  • . Keshtkar M, Shahbazi-Gahrouei D, Khoshfetrat SM, Mehrgardi MA, Aghaei ...
  • . Yang L, Peng XH, Wang YA, Wang X, Cao ...
  • . Rasaneh S, Rajabi H, Babaei MH, Akhlaghpoor S. MRI ...
  • . Chen TJ, Cheng TH, Chen CY, Hsu SC, Cheng ...
  • . Unterweger H, Janko C, Schwarz M, Dézsi L, Urbanics ...
  • نمایش کامل مراجع